New recommendations from US health authorities regarding hepatitis B vaccination are projected to have dire consequences, according to multiple studies published in recent weeks. The changes to vaccination guidelines have alarmed public health experts, who warn that reduced vaccination coverage could lead to significant increases in preventable hepatitis B infections, particularly among vulnerable populations.
The studies project that the revised recommendations, which alter the timing and target groups for hepatitis B vaccination, could result in thousands of additional infections annually. Hepatitis B is a serious liver infection that can become chronic and lead to cirrhosis, liver failure, and liver cancer. The virus is transmitted through contact with infected blood and body fluids, making vaccination a critical tool for prevention.
Public health organizations have called for the recommendations to be revisited, arguing that the existing vaccination strategy had been effective in dramatically reducing hepatitis B incidence in the United States. They express concern that any weakening of vaccination requirements could reverse decades of progress in controlling the disease.
In related health news, the Trump administration has warned against using federal dollars for fentanyl test strips, a harm reduction tool that public health advocates consider essential for preventing overdose deaths. The administration's position has drawn criticism from addiction specialists and harm reduction organizations, who argue that test strips save lives and should be widely accessible.
The Supreme Court is also grappling with a multibillion-dollar wave of lawsuits over Roundup cancer claims, hearing arguments about how risks of the popular weed killer should be labeled.